Download | < Back |
29 May 2020 | |
Press Release relating to approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients, which we shall be releasing after sending this letter to you. This is for your information and record.<BR> <BR> Thanking you,<BR> | |
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. | Source: BSE India |